CAI's Strategic Partnership with JLL Partners: A New Era of Opportunities
CAI, a dedicated firm in operational readiness and excellence within the life sciences sector and mission-critical environments, has recently announced the successful completion of its recapitalization transaction with JLL Partners, a middle-market private equity firm based in New York. This milestone is expected to accelerate CAI's global expansion initiatives, technological advancements, and service enhancements across its offerings.
Overview of the Partnership
The closing of this recapitalization transaction signifies a crucial step in CAI's mission to enhance its service capabilities for global clients, including their recent expansions into Australia and collaborations focused on cutting-edge technology. With JLL's support, CAI is poised to invest strategically in talent acquisition, training programs, state-of-the-art technologies, and valuable strategic acquisitions. Furthermore, there will be a keen focus on maintaining a thriving workplace culture, attracting top-tier professionals in the highly regulated sectors in which CAI operates.
For over three decades, CAI has consistently delivered operational readiness services to critical industry clients, characterized by technical rigor, precision, and consistency. The partnership with JLL Partners is designed to leverage the company's extensive technical expertise and strong client relationships forged by its robust team of over 700 professionals working across North America, Europe, Australia, and Asia. This collaboration will further enable CAI to deepen its commitment to its workforce, enhance its platform, and expand its global capabilities.
Insights from CAI Leadership
Sheena Dempsey, CEO of CAI, expressed her enthusiasm regarding the transaction, stating, "The successful closure of this transaction has enabled us to forge a solid alliance with JLL that will enhance and broaden our service offerings as we explore new technologies and markets." This optimistic outlook highlights the synergy expected from this new partnership, which aligns closely with CAI's overarching business strategy.
Similarly, Phil Pursifull, CAI's CFO, reflected on his long tenure at CAI, describing this phase as one of the most exhilarating in the company's history. "We are witnessing substantial demand from clients and ongoing advancements across the technologies and markets we serve, creating an immense opportunity for investment in the people and culture that have always set us apart."
The recapitalization also received a boost from NewVale Capital, a growth equity firm specializing in investments for the life sciences services sector, playing a key role as a co-investor in this significant transaction.
Financial Advisory and Strategic Partners
In addition to JLL Partners, Bourne Partners and Stifel served as financial advisors to JLL during the transaction, whereas Stout provided financial advisory services to CAI. This robust advisory support underscores the careful planning and strategic vision behind the recapitalization, ensuring that CAI is optimally positioned for future growth.
The Path Forward
As CAI steps into this new phase of growth, it aims to redefine operational excellence, agility, and resilience within its sector. By continuously adopting innovative practices and driving digital transformation, CAI is setting the stage for a future of unprecedented opportunities for its clients and stakeholders alike. The firm’s commitment to excellence will undoubtedly resonate across its operations as it embarks on this transformational journey.
For more information about CAI, visit
https://caiready.com.
About JLL Partners
JLL Partners, LLC, boasts over three decades of experience in transforming middle-market companies predominantly in the health, industrial, and business services sectors. They strive to partner with firms capable of becoming market leaders through strategic mergers & acquisitions, organic growth initiatives, and operational improvements.
For further insight into JLL Partners, please explore
www.jllpartners.com.
About NewVale Capital
Founded in 2021, NewVale Capital specializes in growth equity investments within the pharmaceutical services sector, targeting proven and revenue-generating service companies and tech innovations serving the life sciences ecosystem.
Learn more at
www.newvalecapital.com.